Trials / Completed
CompletedNCT06994052
Study on Booster Immunization With Varicella Vaccine at Different Intervals
A Phase Ⅳ Clinical Trial to Evaluate the Immunogenicity and Safety of Booster Immunization With Varicella Vaccine at Different Intervals Among Children Aged 7-12 Years
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 412 (actual)
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 7 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to evaluate the immunogenicity and safety of booster immunization of varicella live attenuated vaccine (varicella vaccine hereafter) at different intervals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Varicella vaccine | lyophilized powder, subcutaneous injection |
Timeline
- Start date
- 2024-09-21
- Primary completion
- 2024-11-30
- Completion
- 2024-11-30
- First posted
- 2025-05-29
- Last updated
- 2025-05-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06994052. Inclusion in this directory is not an endorsement.